No registrations found.
ID
Source
Brief title
Health condition
sirgical site infections
primary total knee replacement
primary total hip replacement
diepe wondinfecties
totale heup prothese
totale knie prothese
eradicatie kuur
Sponsors and support
Intervention
Outcome measures
Primary outcome
Reduction in surgical site infection
Secondary outcome
Decolonization of S. aureus, swabs during surgery and before start intervention
Study objective
Mupirocin nasal ointment and chlorhexidine soap, reduces the risk of hospital-associated S. aureus infection in primary hip and knee replacement
Study design
Inclusion will take three years in total, after inclusion follow-up will be one year. After four years all patients have enrolled the study with a minimal follow-up of one year
Intervention
The intervention and control group starts five days before surgey with nasal ointment and bathing
Inclusion criteria
- All patients have to be mentally competent
- Informed consent
- Age above 18
- Primary total hip replacement or
primary total knee replacement
Exclusion criteria
- Not mentally competent
- Allergy for substances
- No previous hip or knee surgery before
(arthroscopy is allowed)
Design
Recruitment
Followed up by the following (possibly more current) registration
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL4605 |
| NTR-old | NTR4756 |
| CCMO | NL32100.075.11 |
| OMON | NL-OMON41616 |